Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription 30.06.2025 3 Ann Surg Oncol 8 Anticancer Res 2 Br J Surg 1 Cancer 2 Cancer Lett 1 Dis Colon Rectum 8 Eur J Surg Oncol 1 Gastroenterology 2 Gut 1 Int J Cancer 2 Int J Colorectal Dis 1 Int J Oncol 1 J Clin Oncol 1 J Pathol 1 J Surg Oncol 1 Oncogene 4 PLoS One 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
   Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
   Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363.
   PubMed         Abstract available
   
   
2. SASSUN R, Sileo A, Ng JC, Brucchi F, et al
   ASO Visual Abstract: Oncological Outcomes of Neoadjuvant Chemotherapy Versus Upfront Surgery in Locally Advanced Colon Cancer: A Systematic Review, Meta-analysis, and Sequential Analysis.
   Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17722.
   PubMed        
   
   
3. KHALIL M, Woldesenbet S, Rashid Z, Altaf A, et al
   The Hidden Burden: Impact of Allostatic Load on Colorectal Cancer Surgery Outcomes.
   Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17711.
   PubMed         Abstract available
   
   

   
   Anticancer Res

4. SUETSUGU F, Tadokoro T, Fujita K, Fujihara S, et al
   Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study.
   Anticancer Res. 2025;45:2937-2947.
   PubMed         Abstract available
   
   
5. VAN BUSSEL MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al
   Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial.
   Anticancer Res. 2025;45:3137-3147.
   PubMed         Abstract available
   
   
6. NGUYEN MLT, Bui LA, Pham C, Nham PLT, et al
   Adiponectin Receptor Agonist Suppresses Human Colorectal Cancer.
   Anticancer Res. 2025;45:3059-3068.
   PubMed         Abstract available
   
   
7. KANG BM, Han Q, Li S, Mizuta K, et al
   The Conditions of Non-rescuability of Methioninase-treated Cancer Cells by Methionine Replenishment: The Point of No Return.
   Anticancer Res. 2025;45:2817-2823.
   PubMed         Abstract available
   
   
8. LEE J, Kim H, Moon J, Nualsanit T, et al
   Damnacanthal Suppresses TCF4 Expression in Colorectal Cancer Cells.
   Anticancer Res. 2025;45:2847-2858.
   PubMed         Abstract available
   
   
9. KIM J, Han Q, Kang BM, Mizuta K, et al
   The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells.
   Anticancer Res. 2025;45:2773-2779.
   PubMed         Abstract available
   
   
10. ASANO Y, Han Q, Li S, Mizuta K, et al
    The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human Fibroblasts.
    Anticancer Res. 2025;45:2825-2831.
    PubMed         Abstract available
    
    
11. HUANG CW, Yang JS, Tsai YF, Kuo SC, et al
    Anti-cancer Effects of a Novel Curcumin Derivative, 4,4-Diallyl Curcumin Bis(2,2-Hydroxymethyl)Propanoate (35e), on Radio-resistant Colorectal Cancer Cells.
    Anticancer Res. 2025;45:2891-2904.
    PubMed         Abstract available
    
    

    
    Br J Surg

12. FLETCHER JA, Corr A, Drami I, Taylor C, et al
    Enhancing decision-making and patient comprehension in complex rectal cancer surgery through personalized three-dimensional imaging: randomized feasibility study.
    Br J Surg. 2025;112:znaf116.
    PubMed         Abstract available
    
    
13. 
    Correction to: Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.
    Br J Surg. 2025;112:znaf135.
    PubMed        
    
    

    
    Cancer

14. SCHULTZ KS, Bansal VV, Wach MM, Bhutiani N, et al
    Consensus guideline for the management of colorectal cancer with peritoneal metastases.
    Cancer. 2025;131:e35869.
    PubMed         Abstract available
    
    

    
    Cancer Lett

15. YU C, Lu W, Wu J, Fang X, et al
    Liver metastasis or peritoneal metastasis: single-cell RNA sequencing reveals the organotropism in colorectal cancer is driven by distinct partial-EMT processes.
    Cancer Lett. 2025 Jun 17:217880. doi: 10.1016/j.canlet.2025.217880.
    PubMed         Abstract available
    
    
16. KHAN S, Karmokar A, Howells L, Britton RG, et al
    An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes.
    Cancer Lett. 2025 Jun 19:217885. doi: 10.1016/j.canlet.2025.217885.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

17. SUI Q, Liao L, Yu JH, Zhang L, et al
    Surgical Outcomes in Metastatic Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer Following Disease Control with Immune Checkpoint Inhibition: A Retrospective Observational Study.
    Dis Colon Rectum. 2025 Jun 27. doi: 10.1097/DCR.0000000000003845.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

18. BOLDRINI L, Charles-Davies D, Romano A, Mancino M, et al
    Response prediction for neoadjuvant treatment in locally advanced rectal cancer patients-improvement in decision-making: A systematic review.
    Eur J Surg Oncol. 2025;51:109463.
    PubMed         Abstract available
    
    
19. FOPPA C, Maroli A, Carvello M, La Raja C, et al
    Long-term functional outcomes after Transanal Transection and Single-Stapled (TTSS) anastomosis for rectal cancer measured by electronic Patients Reported Outcome Measures (ePROMs).
    Eur J Surg Oncol. 2025;51:109759.
    PubMed         Abstract available
    
    
20. BHIMANI N, Dieng M, Kelly PJ, Hugh TJ, et al
    Colorectal liver metastasis resection results in excellent long-term quality of life and low symptom burden.
    Eur J Surg Oncol. 2025;51:109751.
    PubMed         Abstract available
    
    
21. BANKEN E, Creemers DMJ, Kerckhove FECV, Ketelaers SHJ, et al
    Palliative management of patients with locally recurrent rectal cancer: Clinical presentation, treatment strategies, and overall survival.
    Eur J Surg Oncol. 2025;51:109758.
    PubMed         Abstract available
    
    
22. JEHAES C, Panis Y, Fernandez L, Lelong B, et al
    Risk of distant metastasis after local excision for near-complete response versus salvage surgery for local regrowth in rectal cancer: Results from an international registry.
    Eur J Surg Oncol. 2025;51:109761.
    PubMed         Abstract available
    
    
23. WETTERHOLM E, Ronnow CF, Thorlacius H
    Risk of recurrence following transanal endoscopic microsurgery without neoadjuvant or adjuvant treatment in T2 rectal cancer.
    Eur J Surg Oncol. 2025;51:109974.
    PubMed         Abstract available
    
    
24. POWELL SG, Wyatt JNR, Rao C, Dhadda A, et al
    Contact X-ray brachytherapy in rectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:109976.
    PubMed         Abstract available
    
    
25. ABUDUAINI N, Wang X, Fingerhut A, Zheng M, et al
    Short-term outcomes of transanal endoscopic intersphincteric resection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A single-center retrospective cohort study.
    Eur J Surg Oncol. 2025;51:109984.
    PubMed         Abstract available
    
    

    
    Gastroenterology

26. HONG YR, Liu-Galvin R, Xie Z
    Association of USPSTF Guideline Expansion with Colorectal Cancer Screening Uptake and Recommendations among Adults aged 45-49.
    Gastroenterology. 2025 Jun 9:S0016-5085(25)00846.
    PubMed        
    
    

    
    Gut

27. FRAZZONI L, Antonelli G, Pilonis ND, Wisse PHA, et al
    Adenoma detection and subsequent colorectal cancer risk: is the race really over?
    Gut. 2025 Jun 27:gutjnl-2025-335225. doi: 10.1136/gutjnl-2025-335225.
    PubMed        
    
    
28. CAO J, Qin S, Li B, Zhang Z, et al
    Extracellular vesicle-induced lipid dysregulation drives liver premetastatic niche formation in colorectal cancer.
    Gut. 2025 Jun 25:gutjnl-2025-334851. doi: 10.1136/gutjnl-2025-334851.
    PubMed         Abstract available
    
    

    
    Int J Cancer

29. CHAPLIN A, Rodriguez RM, Barcelo-Nicolau M, Perez-Romero K, et al
    Plasma fatty acids depletion: A metabolic signature related to colon cancer.
    Int J Cancer. 2025 Jun 23. doi: 10.1002/ijc.70015.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

30. LI G, Zhang X, Qiu X, Xu L, et al
    Clinical characteristics and survival outcomes of rectal cancer patients across different mrT3 substages determined by rectal MRI.
    Int J Colorectal Dis. 2025;40:147.
    PubMed         Abstract available
    
    
31. TURAN B, Sanli AN, Sanli DET, Acar S, et al
    Prognostic impact and independent significance of tumor deposits in early-stage colon cancer: a population-based cohort study.
    Int J Colorectal Dis. 2025;40:146.
    PubMed         Abstract available
    
    

    
    Int J Oncol

32. PAN S, Deng Y, Fu J, Zhang Y, et al
    [Retracted] N6?methyladenosine upregulates miR?181d?5p in exosomes derived from cancer?associated fibroblasts to inhibit 5?FU sensitivity by targeting NCALD in colorectal cancer.
    Int J Oncol. 2025;67:62.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

33. ASSENAT E, Ben Abdelghani M, Gourgou S, Perrier H, et al
    Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial.
    J Clin Oncol. 2025 Jun 20:JCO2402754. doi: 10.1200/JCO-24-02754.
    PubMed         Abstract available
    
    

    
    J Pathol

34. WARD JC, Morgan M, Wood J, Woolley C, et al
    Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.
    J Pathol. 2025 Jun 22. doi: 10.1002/path.6446.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

35. DONE JZ, Papanikolaou A, Stem M, Radomski SN, et al
    Impact of Neoadjuvant Chemotherapy on Perioperative Morbidity in Combined Resection of Rectal Cancer and Liver Metastases.
    J Surg Oncol. 2025;131:1384-1392.
    PubMed         Abstract available
    
    

    
    Oncogene

36. WU H, Hu X, Wang Y, Zhu X, et al
    RBM5 recruiting MGC32805 in a sandwich mode and inducing DeltaFAS neoantigen and triggering FAS properties switch: implication in colorectal cancer.
    Oncogene. 2025 Jun 26. doi: 10.1038/s41388-025-03390.
    PubMed         Abstract available
    
    

    
    PLoS One

37. WU W, Li A, Singh V, Salner A, et al
    Pain, fatigue, and associated gene expressions over chemotherapy in patients with colorectal cancer.
    PLoS One. 2025;20:e0325849.
    PubMed         Abstract available
    
    
38. CHO NY, Kim S, Hadaya J, Chervu N, et al
    Association of center-level operative volume and acute outcomes following robotic-assisted colectomy for colorectal cancer.
    PLoS One. 2025;20:e0299174.
    PubMed         Abstract available
    
    
39. ABDELMAKSOUD-DAMMAK R, Ammous-Boukhris N, Saadallah-Kallel A, Ayed-Guerfali DB, et al
    Genetic profiling of inherited colorectal cancer syndromes in Tunisian patients.
    PLoS One. 2025;20:e0326343.
    PubMed         Abstract available
    
    
40. AOKI Y, Miki A, Sakuma Y, Watanabe J, et al
    Clinical impact of low bone mineral density in patients with colorectal cancer liver metastasis undergoing hepatectomy.
    PLoS One. 2025;20:e0324719.
    PubMed         Abstract available
    
    

    
    World J Surg

41. DADHWAL US
    Letter to the Editor: Intraoperative Blood Loss Predicts Local Recurrence After Curative Resection for Stage I-III Colorectal Cancer.
    World J Surg. 2025 Jun 24. doi: 10.1002/wjs.12686.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.